Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

NCT00470704 is registered in ClinicalTrials.gov with Nancy Lin, MD as lead sponsor.

NCT NCT00470704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00470704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Lead sponsor
Nancy Lin, MD
Phase
Phase 2
Overall status
Completed
Start date
May 14, 2007
Completion date
August 20, 2024
Enrollment
87 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer